Last reviewed · How we verify
NCT05105503
Dialysis Access Monitoring Using a Digital Stethoscope-Based Deep Learning System
trial testing Eko CORE Digital Stethoscope in Dialysis Access Malfunction in 22 participants. Completed in 31 December 2024.
31 December 2024
Quick facts
| Lead sponsor | Eko Devices, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 22 |
| Start date | 23 May 2022 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Eko CORE Digital Stethoscope
Conditions studied
- Dialysis Access Malfunction — all drugs for Dialysis Access Malfunction →
- Dialysis; Complications — all drugs for Dialysis; Complications →
Sponsor
Eko Devices, Inc. — full company profile →
Who can join
18 and older, any sex, with Dialysis Access Malfunction or Dialysis; Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will enroll end-stage renal disease (ESRD) patients on hemodialysis with a maturing arteriovenous fistula (AVF) for hemodialysis access. A study staff member will mark with indelible ink on each participant's skin the three sites on the upper extremity where the Eko CORE digital stethoscope will be used to take sound recordings. 9 recordings will be taken (3 at each site) once per week during weekly dialysis treatments.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05105503
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dialysis Access Malfunction
Currently open trials in the same condition.
- NCT06553443 — Randomised Clinical Trial Comparing Drug-coated Balloon to Plain Balloon for All Peripheral AVF Stenosis · Phase 3 · recruiting
Other Eko Devices, Inc. trials
Trials by the same sponsor.
- NCT07270744 — Data Collection Using Eko Devices in a Clinical Setting · recruiting
- NCT07227376 — Data Collection Using Eko Digital Devices in a Clinical Setting · recruiting
- NCT07270692 — Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence · recruiting
- NCT07136623 — Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope · recruiting
- NCT07087613 — Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05105503 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eko Devices, Inc.
- Last refreshed: 25 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05105503.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing